Description
Orserdu (elacestrant) is an oral SERD for ER+/HER2- ESR1-mutated advanced or metastatic breast cancer.
$2,315.34
Oral SERD for breast cancer
Orserdu (elacestrant) is an oral SERD for ER+/HER2- ESR1-mutated advanced or metastatic breast cancer.
Reviews
There are no reviews yet.